Alvin Luk, Founder of Neurophth Therapeutics

Alvin Luk is the founder of Neurophth Therapeutics. Neurophth Therapeutics has raised $125M in total funding. Latest round: Series C+.

About Alvin Luk

Alvin Luk is the founder and scientific leader of Neurophth Therapeutics, a biotech company focused on developing gene therapies for Leber hereditary optic neuropathy (LHON). He has presented clinical data on the safety and efficacy of their rAAV2-ND4 gene therapy and oversees strategic partnerships.

Alvin Luk at a glance

More founder profiles (44)

Browse related founder lists (5)

Full founder directory · Investor directory · Company funding database · Fundraising library